• FDA-compliant tissue microarrays
    FDA compliant tissue microarray. (courtesy: AMSBIO)

Laboratory Products

FDA-compliant tissue microarrays

Jun 19 2024

AMSBIO is pleased to announce the expansion of its range of FDA-compliant tissue microarrays (TMAs), enhancing their utility in tissue cross-reactivity (TCR) and target validation studies. These high-quality TMAs facilitate high-throughput analysis of diverse tissue types recognised by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Each TMA integrates multiple normal tissue types from three distinct donor samples on a single slide, enabling concurrent analysis and aiding in the identification of potential cross-reactive and off-target epitopes previously unobserved. Early detection of such insights during the discovery phase helps mitigate costly errors in diagnostic tests and undesired side effects from therapeutic agents.

These TMAs feature tissue cores validated and quality-controlled by licensed pathologists, arriving pre-mounted and ready-to-use. They support cost-effective, high-throughput analysis while ensuring clinical relevance through rigorous quality assurance measures.

Dr Phillip Pridham-Field, AMSBIO’s Business Unit Manager for Biorepository, remarked: “Our FDA-compliant tissue microarrays provide a rapid, cost-effective means for validating biological targets across multiple tissue samples.” He added: “Concurrent analysis of multiple specimens not only reduces operational time and conserves reagents but also enables high-throughput molecular tissue analysis.”

In addition to FDA-compliant controls, AMSBIO offers an extensive selection of over two thousand tissue microarrays for advanced biomarker and drug target validation research. All TMAs are sourced from AMSBIO’s extensive repository of normal human and animal tissues, alongside multiple tumour-type tissue arrays.

More information online


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

EMC2024

Aug 25 2024 Copenhagen, Denmark

View all events